Skip to content

Effect of adjunctive electrochemical implant surface decontamination in the treatment of periimplantitis: A randomised controlled clinical trial

Effect of adjunctive electrochemical implant surface decontamination in the treatment of periimplantitis: A randomised controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00033883
Enrollment
20
Registered
2024-03-13
Start date
2024-04-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

T84.7

Interventions

Group 1: The first group receives resective, regenerative or combined peri-implantitis treatment with decontamination of the implant surfaces according to the previous standard with curettes, ultrason

Sponsors

Mund-Kiefer-Gesichtschirurgie des Klinikums der Universität München LMU
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Medically healthy adult (ASA classification I-II, age = 18 years old) - Non-smoker - Good oral hygiene (FMPS & FMBS = 25 %) - Patient willing to give written informed consent - Ability and willingness to follow study procedures - periodontally without pathological findings or successfully treated - implants with unresolved periimplantitis as defined by the 2018 World Workshop (Stefan Renvert et al., 2018): 1. Evidence of visual inflammatory changes in the peri-implant soft tissues combined with bleeding on probing and/or suppuration 2. Increasing probing pocket depths as compared to measurements obtained at placement of the supra-structure; and 3. Progressive bone loss in relation to the radiographic bone level assessment at 1 year following the delivery of the implant-supported prosthetics reconstruction; and 4. In the absence of initial radiographs and probing depths, radiographic evidence of bone level =3 mm and/or probing depths =6 mm in conjunction with profuse bleeding represents peri-implantitis - more than 2mm keratinized and at the same time attached periimplant mucosa

Exclusion criteria

Exclusion criteria: - Pregnant, intending to conceive or breast feeding - hematologic diseases, immunosuppression and collagenosis - untreated periodontitis - No written informed consent - Implant mobility - irrational to treat (bone loss around the implant >75% or less <3mm remaining periimplant bone) - less than 2mm keratinized periimplant mucosa - less than 2mm attached periimplant mucosa

Design outcomes

Primary

MeasureTime frame
-treatment success = absence of periimplantitis according to Herrera et. al. 2023 -implant survival

Secondary

MeasureTime frame
-periimplant mucositis -probing pocket depths

Countries

Germany

Contacts

Public ContactPhilip Stähler

Mund-Kiefer-Gesichtschirurgie des Klinikums der Universität München LMU

Philip.Staehler@med.uni-muenchen.de+49894400052971

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026